Pharmaceutical Business review

RainDance Technologies launches solution for rare cancer mutation detection

The DeepSeq Solution is based on the proven RainStorm microdroplet-based single molecule PCR technology and is optimised for both fresh frozen and FFPE tissue.

It delivers high specificity, accurate quantification, unbiased allelic representation, and enables the discovery of rare cancer mutations that represent as little as one percent of a heterogeneous tumour.

It runs on the RDT 1000 – an automated instrument that produces two million single molecule microdroplet-PCR reactions per sample in a single tube in less than one hour.